Publications by authors named "Martin Felices"

Claim this Profile
C
Correction: Natural killer cell infiltration in prostate cancers predict improved patient outcomes.
Nicholas A Zorko, Allison Makovec, Andrew Elliott, Samuel Kellen, John R Lozada, Martin Felices

Prostate Cancer Prostatic Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic NK cell activation results in a dysfunctional, tissue resident-like state mediated by KLF2 deficiency.
Jacob A Myers, Rih-Sheng Huang, Shee Kwan Phung, Jeremy M Chacón, Laura Bendzick, Martin Felices

Blood· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TGF-βRII/IL-15 immunotherapeutic complex targets exhausted CD8 T-cell subsets in lymph nodes and tumors.
Varghese K George, Hing C Wong, Martin Felices, Mark P Rubinstein, Niraj Shrestha

J Immunother Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The transcription factor BCL11B drives NK cell cytotoxicity and antitumor activity.
Akhilesh Kumar, Bin Zhang, Andrew Baldys, Colin Fischer, Alexander Lenvik, Martin Felices

J Immunol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA class I expression shapes the tumor immune microenvironment and influences prognosis in prostate cancer.
Pornlada Likasitwatanakul, Carissa Besonen, Alexander K Tsai, Negar Sadeghipour, Andrew Elliott, Martin Felices

Prostate Cancer Prostatic Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel trispecific killer engager targeting B7-H3 enhances natural killer cell antitumor activity against head and neck cancer.
Melissa J Khaw, Nicholas A Zorko, Philippa R Kennedy, Laura E Bendzick, Madison Shackelford, Martin Felices

J Immunother Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes.
Nicholas A Zorko, Allison Makovec, Andrew Elliott, Samuel Kellen, John R Lozada, Martin Felices

Prostate Cancer Prostatic Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A PSMA-Targeted Tri-Specific Killer Engager Enhances NK Cell Cytotoxicity against Prostate Cancer.
Shee Kwan Phung, Nicholas A Zorko, Yvette Soignier, Rhett L Waller, Madison Shackelford, Martin Felices

Cancer Immunol Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD56 cytokine-induced memory-like NK cells and NK-cell engagers synergize against non-small cell lung cancer cancer-stem cells.
Maria L Guevara Lopez, Ann Gebo, Monica Parodi, Stefano Persano, Josephine Maus-Conn, Martin Felices

J Immunother Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-803, an IL-15 Superagonist Complex as Maintenance Therapy After Allogeneic Donor Stem Cell Transplant for Acute Myeloid Leukemia or Myelodysplastic Syndrome; A Phase 2 Trial.
Aimee Merino, Claudio C Brunstein, Ryan Shanley, Faridullah Rashid, Rose Wangen, Martin Felices

Transplant Cell Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic programs drive function of therapeutic NK cells in hypoxic tumor environments.
Philippa R Kennedy, Upasana Sunil Arvindam, Shee Kwan Phung, Brianna Ettestad, Xueyang Feng, Martin Felices

Sci Adv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells.
Anders W Matson, Rob Hullsiek, Kate J Dixon, Sam Wang, Anders J Lindstedt, Martin Felices

J Immunother Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells.
Anders W Matson, Rob H Hullsiek, Kate J Dixon, Sam Wang, Anders J Lindstedt, Martin Felices

bioRxiv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reverse Translation Identifies the Synergistic Role of Immune Checkpoint Blockade and IL15 to Enhance Immunotherapy of Ovarian Cancer.
Martin Felices, Erin Wesley, Laura E Bendzick, Behiye Kodal, Rachel Hopps

Cancer Immunol Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ablation of SYK Kinase from Expanded Primary Human NK Cells via CRISPR/Cas9 Enhances Cytotoxicity and Cytokine Production.
James D Dahlvang, Jenna K Dick, Jules A Sangala, Philippa R Kennedy, Emily J Pomeroy, Martin Felices

J Immunol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality.
Shernan G Holtan, Constanza Savid-Frontera, Kelly Walton, Anne A Eaton, Connor Demorest, Martin Felices

Clin Cancer Res· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A tri-specific killer engager against mesothelin targets NK cells towards lung cancer.
Philippa R Kennedy, Daniel A Vallera, Brianna Ettestad, Caroline Hallstrom, Behiye Kodal, Martin Felices

Front Immunol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual antigen-targeted off-the-shelf NK cells show durable response and prevent antigen escape in lymphoma and leukemia.
Frank Cichocki, Jodie P Goodridge, Ryan Bjordahl, Sajid Mahmood, Zachary B Davis, Martin Felices

Blood· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive single-KIRNKG2C NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia.
Alvaro Haroun-Izquierdo, Marianna Vincenti, Herman Netskar, Hanna van Ooijen, Bin Zhang, Martin Felices

J Immunother Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TEM8 Tri-specific Killer Engager binds both tumor and tumor stroma to specifically engage natural killer cell anti-tumor activity.
Michael F Kaminski, Laura Bendzick, Rachel Hopps, Marissa Kauffman, Behiye Kodal, Martin Felices

J Immunother Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Balanced engagement of activating and inhibitory receptors mitigates human NK cell exhaustion.
Jacob A Myers, Dawn Schirm, Laura Bendzick, Rachel Hopps, Carly Selleck, Martin Felices

JCI Insight· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges to the broad application of allogeneic natural killer cell immunotherapy of cancer.
Philippa R Kennedy, Martin Felices, Jeffrey S Miller

Stem Cell Res Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formation.
Jianbo Yang, Qianjin Liao, Matthew Price, Branden Moriarity, Natalie Wolf, Martin Felices

Transl Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy.
Karrune V Woan, Hansol Kim, Ryan Bjordahl, Zachary B Davis, Svetlana Gaidarova, Martin Felices

Cell Stem Cell· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Putting On the Gas and Taking Off the Brakes: A Novel Combinatorial Strategy to Enhance Tumor-Infiltrating Lymphocytes.
Martin Felices, Jeffrey S Miller

Cancer Immunol Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis